In summary, this study aims to predict the HER-2 expression status of breast cancer patients by combining machine learning and deep learning models using ultrasound Radiomics data to provide a more reliable basis for developing treatment strategies and prognostic assessment. Here, ERBB2 is linked to breast carcinoma.